M. Easwar

GlaxoSmithKline (United States)

Papers

1

Total Citations

4

H-Index

1

About

M. Easwar is a researcher advancing the field of real-world evidence (RWE) generation through automation and scalable data processing. Their key research areas include clinical data management, automated data collection, and the integration of artificial intelligence to streamline healthcare analytics. Easwar’s major contribution, as highlighted in their most-cited work "PNS271 Automation in Routine Use for Data Collection and Processing for Scalable Faster RWE Generation" (2020, 4 citations), demonstrates a practical framework for deploying automated systems in routine clinical settings to accelerate the generation of reliable RWE. This work addresses critical bottlenecks in data curation, enabling faster insights for regulatory and clinical decision-making. While their citation count is modest, the work’s focus on operational efficiency and scalability positions it as a foundational reference for researchers seeking to implement automation in real-world studies. Easwar’s achievements underscore a commitment to bridging the gap between raw clinical data and actionable evidence, making their research particularly valuable for students and professionals interested in health informatics, pharmacoepidemiology, and the practical application of AI in healthcare.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
PNS271 Automation in Routine Use for Data Collection and Processing for Scalable Faster RWE Generation
4 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: GlaxoSmithKline (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago